{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:10:48Z","timestamp":1794571848904,"version":"4.9.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100025154","name":"University of Sadat City","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100025154","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Foot-and-mouth disease (FMD) is a highly contagious and transmissible disease that can have significant economic and trade repercussions during outbreaks. In Egypt, despite efforts to mitigate FMD through mandatory immunization, the disease continues to pose a threat due to the high genetic variability and quasi-species nature of the FMD virus (FMDV). Vaccines have been crucial in preventing and managing FMD, and ongoing research focusses on developing next-generation vaccines that could provide universal protection against all FMDV serotypes. This review thoroughly examines the genetic structure of FMDV, including its polyprotein cleavage process and the roles of its structural and non-structural proteins in immune evasion. Additionally, it explores topics such as antigenic sites, specific mutations, and serotype relationships from Egypt and Ethiopia, as well as the structural changes in FMDV serotypes for vaccine development. The review also addresses the challenges associated with creating effective vaccines for controlling FMD, particularly focusing on the epitope-based vaccine. Overall, this review offers valuable insights for researchers seeking to develop effective strategies and vaccines for controlling FMD.<\/jats:p>","DOI":"10.1186\/s13567-025-01485-0","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:17:32Z","timestamp":1744003052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Foot-and-mouth disease: genomic and proteomic structure, antigenic sites, serotype relationships, immune evasion, recent vaccine development strategies, and future perspectives"],"prefix":"10.1186","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-9888","authenticated-orcid":false,"given":"Alyaa","family":"Elrashedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Nayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Zaghawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan M.","family":"El-Shabasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","volume":"112","author":"TJD Knight-Jones","year":"2013","unstructured":"Knight-Jones TJD, Rushton J (2013) The economic impacts of foot and mouth disease \u2013 What are they, how big are they and where do they occur? Prev Vet Med 112:161\u2013173. https:\/\/doi.org\/10.1016\/j.prevetmed.2013.07.013","journal-title":"Prev Vet Med"},{"key":"1485_CR2","doi-asserted-by":"publisher","first-page":"1360256","DOI":"10.3389\/fvets.2024.1360256","volume":"11","author":"AK Wubshet","year":"2024","unstructured":"Wubshet AK, Werid GM, Teklue T, Zhou L, Bayasgalan C, Tserendorj A, Liu J, Heath L, Sun Y, Ding Y, Wang W, Zaberezhny AD, Liu Y, Zhang J (2024) Foot and mouth disease vaccine efficacy in Africa: a systematic review and meta-analysis. Front Vet Sci 11:1360256. https:\/\/doi.org\/10.3389\/fvets.2024.1360256","journal-title":"Front Vet Sci"},{"key":"1485_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","volume":"17","author":"MJ Grubman","year":"2004","unstructured":"Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17:465\u2013493. https:\/\/doi.org\/10.1128\/CMR.17.2.465-493.2004","journal-title":"Clin Microbiol Rev"},{"key":"1485_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/v14051009","volume":"14","author":"E Brown","year":"2022","unstructured":"Brown E, Nelson N, Gubbins S, Colenutt C (2022) Airborne transmission of foot-and-mouth disease virus: a review of past and present perspectives. Viruses 14:1009. https:\/\/doi.org\/10.3390\/v14051009","journal-title":"Viruses"},{"key":"1485_CR5","doi-asserted-by":"publisher","first-page":"1201578","DOI":"10.3389\/fvets.2023.1201578","volume":"10","author":"M Aslam","year":"2023","unstructured":"Aslam M, Alkheraije KAA (2023) The prevalence of foot-and-mouth disease in Asia. Front Vet Sci 10:1201578. https:\/\/doi.org\/10.3389\/fvets.2023.1201578","journal-title":"Front Vet Sci"},{"key":"1485_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijvsm.2018.02.001","volume":"6","author":"NM Sobhy","year":"2018","unstructured":"Sobhy NM, Bayoumi YH, Mor SK, El-Zahar HI, Goyal SM (2018) Outbreaks of foot and mouth disease in Egypt: Molecular epidemiology, evolution and cardiac biomarkers prognostic significance. Int J Vet Sci Med 6:22\u201330. https:\/\/doi.org\/10.1016\/j.ijvsm.2018.02.001","journal-title":"Int J Vet Sci Med"},{"key":"1485_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1297-9716-44-116","volume":"44","author":"SM Jamal","year":"2013","unstructured":"Jamal SM, Belsham GJ (2013) Foot-and-mouth disease: Past, present and future. Vet Res 44:116. https:\/\/doi.org\/10.1186\/1297-9716-44-116","journal-title":"Vet Res"},{"key":"1485_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/v12090990","volume":"12","author":"RSA El","year":"2020","unstructured":"El RSA, Hoffmann B, Karam R, El-Beskawy M, Hamed MF, Forth LF, H\u00f6per D, Eschbaumer M (2020) Sequence analysis of Egyptian foot-and-mouth disease virus field and vaccine strains: intertypic recombination and evidence for accidental release of virulent virus. Viruses 12:990. https:\/\/doi.org\/10.3390\/v12090990","journal-title":"Viruses"},{"key":"1485_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1099\/vir.0.18859-0","volume":"84","author":"ADS Bastos","year":"2003","unstructured":"Bastos ADS, Haydon DT, Sangar\u00e9 O, Boshoff CI, Edrich JL, Thomson GR (2003) The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. J Gen Virol 84:1595\u20131606. https:\/\/doi.org\/10.1099\/vir.0.18859-0","journal-title":"J Gen Virol"},{"key":"1485_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5455\/jva.20130219104353","volume":"3","author":"M ElMoety","year":"2013","unstructured":"ElMoety M, ElAty M, Fakry H, Daoud H, Ibrahim E, ElDin W, Rizk S, ElNaga H, Mohamed A, ElKrim A, Farouk E (2013) Isolation and molecular characterization of foot and mouth disease SAT2 virus during outbreak 2012 in Egypt. J Vet Adv 3:60. https:\/\/doi.org\/10.5455\/jva.20130219104353","journal-title":"J Vet Adv"},{"key":"1485_CR11","doi-asserted-by":"publisher","unstructured":"Vosloo W, Bastos ADS, Sangare O, Hargreaves SK, Thomson GR (2002) Review of the status and control of foot and mouth disease in sub-Saharan Africa. Rev Sci Tech 21:437\u2013449. https:\/\/doi.org\/10.20506\/RST.21.3.1349","DOI":"10.20506\/RST.21.3.1349"},{"key":"1485_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3201\/EID1310.070252","volume":"13","author":"NJ Knowles","year":"2007","unstructured":"Knowles NJ, Wadsworth J, Reid SM, Swabey KG, El-Kholy AA, El-Rahman AOA, Soliman HM, Ebert K, Ferris NP, Hutchings GH, Statham RJ, King DP, Paton DJ (2007) Foot-and-mouth disease virus serotype A in Egypt. Emerg Infect Dis 13:1593\u20131596. https:\/\/doi.org\/10.3201\/EID1310.070252","journal-title":"Emerg Infect Dis"},{"key":"1485_CR13","doi-asserted-by":"publisher","unstructured":"Diab E, Bazid A-HI, Fawzy M, El-Ashmawy WR, Fayed AA, El-Sayed MM (2019) Foot-and-mouth disease outbreaks in Egypt during 2013\u20132014: Molecular characterization of serotypes A, O, and SAT2. Vet World 12:190\u2013197. https:\/\/doi.org\/10.14202\/vetworld.2019.190-197","DOI":"10.14202\/vetworld.2019.190-197"},{"key":"1485_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12985-021-01693-Y","volume":"19","author":"AM Hassan","year":"2022","unstructured":"Hassan AM, Zaher MR, Hassanien RT, Abd-El-Moniem MI, Habashi AR, Ibraheem EM, Shahein MA, El Zowalaty ME, Hagag NM (2022) Molecular detection, phylogenetic analysis and genetic diversity of recently isolated foot-and-mouth disease virus serotype A African topotype. Genotype IV Virol J 19:1. https:\/\/doi.org\/10.1186\/S12985-021-01693-Y","journal-title":"Genotype IV Virol J"},{"key":"1485_CR15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/ani11061697","volume":"11","author":"HM El Damaty","year":"2021","unstructured":"El Damaty HM, Fawzi EM, Neamat-Allah ANF, Elsohaby I, Abdallah A, Farag GK, El-Shazly YA, Mahmmod YS (2021) Characterization of foot and mouth disease virus serotype SAT-2 in swamp Water Buffaloes (Bubalus bubalis) under the Egyptian smallholder production system. Animals 11:1697. https:\/\/doi.org\/10.3390\/ani11061697","journal-title":"Animals"},{"key":"1485_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105651","volume":"123","author":"E Al-Ebshahy","year":"2024","unstructured":"Al-Ebshahy E, El-Ansary RE, Zhang J, Badr Y, Rady A, El-Ashram S, Ma Y, Yuan M, Elgendy E (2024) Sequence and phylogenetic analysis of FMD virus isolated from two outbreaks in Egypt. Infect Genet Evol 123:105651. https:\/\/doi.org\/10.1016\/j.meegid.2024.105651","journal-title":"Infect Genet Evol"},{"key":"1485_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00284-024-03944-x","volume":"81","author":"RT Hassanein","year":"2024","unstructured":"Hassanein RT, Abdelmegeed HK, Abdelwahed DA, Zaki AG, Saad AS, Shahein MA, Afify AF, Rohaim MA (2024) Epidemiological and genetic insights of the circulating foot-and-mouth disease virus serotypes in Egypt. Curr Microbiol 81:435. https:\/\/doi.org\/10.1007\/s00284-024-03944-x","journal-title":"Curr Microbiol"},{"key":"1485_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2022.105820","volume":"211","author":"WR ElAshmawy","year":"2023","unstructured":"ElAshmawy WR, Aly SS, Farouk MM (2023) Decision tree risk analysis for FMD outbreak prevention in Egyptian feedlots. Prev Vet Med 211:105820. https:\/\/doi.org\/10.1016\/j.prevetmed.2022.105820","journal-title":"Prev Vet Med"},{"key":"1485_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00705-019-04216-x","volume":"164","author":"M Kamel","year":"2019","unstructured":"Kamel M, El-Sayed A, Vazquez HC (2019) Foot-and-mouth disease vaccines: recent updates and future perspectives. Arch Virol 164:1501\u20131513. https:\/\/doi.org\/10.1007\/s00705-019-04216-x","journal-title":"Arch Virol"},{"key":"1485_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/S13028-020-00519-1","volume":"62","author":"GJ Belsham","year":"2020","unstructured":"Belsham GJ (2020) Towards improvements in foot-and-mouth disease vaccine performance. Acta Vet Scand 62:20. https:\/\/doi.org\/10.1186\/S13028-020-00519-1","journal-title":"Acta Vet Scand"},{"key":"1485_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1010589","volume":"18","author":"JC Ward","year":"2022","unstructured":"Ward JC, Lasecka-Dykes L, Neil C, Adeyemi OO, Gold S, McLean-Pell N, Wright C, Herod MR, Kealy D, Warner E, Jackson T, King DP, Tuthill TJ, Rowlands DJ, Stonehouse NJ (2022) The RNA pseudoknots in foot-and-mouth disease virus are dispensable for genome replication, but essential for the production of infectious virus. PLoS Pathog 18:e1010589. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1010589","journal-title":"PLoS Pathog"},{"key":"1485_CR22","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1128\/JVI.79.10.6487-6504.2005","volume":"79","author":"C Carrillo","year":"2005","unstructured":"Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL (2005) Comparative genomics of foot-and-mouth disease virus. J Virol 79:6487\u20136504. https:\/\/doi.org\/10.1128\/JVI.79.10.6487-6504.2005","journal-title":"J Virol"},{"key":"1485_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/pathogens9030208","volume":"9","author":"I Fish","year":"2020","unstructured":"Fish I, Stenfeldt C, Palinski RM, Pauszek SJ, Arzt J (2020) Into the deep (sequence) of the foot-and-mouth disease virus gene pool: bottlenecks and adaptation during infection in na\u00efve and vaccinated cattle. Pathogens 9:208. https:\/\/doi.org\/10.3390\/pathogens9030208","journal-title":"Pathogens"},{"key":"1485_CR24","doi-asserted-by":"publisher","first-page":"e00067","DOI":"10.1128\/MMBR.00067-17","volume":"82","author":"VI Agol","year":"2018","unstructured":"Agol VI, Gmyl AP (2018) Emergency services of viral RNAs: repair and remodeling. Microbiol Mol Biol Rev 82:e00067\u201317. https:\/\/doi.org\/10.1128\/MMBR.00067-17","journal-title":"Microbiol Mol Biol Rev"},{"key":"1485_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006607","volume":"13","author":"N Malik","year":"2017","unstructured":"Malik N, Kotecha A, Gold S, Asfor A, Ren J, Huiskonen JT, Tuthill TJ, Fry EE, Stuart DI (2017) Structures of foot and mouth disease virus pentamers: Insight into capsid dissociation and unexpected pentamer reassociation. PLoS Pathog 13:e1006607. https:\/\/doi.org\/10.1371\/journal.ppat.1006607","journal-title":"PLoS Pathog"},{"key":"1485_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/VMRR.S408352","volume":"14","author":"F Woldemariyam","year":"2023","unstructured":"Woldemariyam F, Paeshuyse J (2023) Viral Protein 1 (VP1) Sequence-based genetic diversity of SAT 2 FMDV circulating in Ethiopia from 1990 to 2015. Vet Med 14:91\u2013101. https:\/\/doi.org\/10.2147\/VMRR.S408352","journal-title":"Vet Med"},{"key":"1485_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/cancers13071711","volume":"13","author":"BS Ludwig","year":"2021","unstructured":"Ludwig BS, Kessler H, Kossatz S, Reuning U (2021) RGD-binding integrins revisited: how recently discovered functions and novel synthetic ligands (re-)shape an ever-evolving field. Cancers 13:1711. https:\/\/doi.org\/10.3390\/cancers13071711","journal-title":"Cancers"},{"key":"1485_CR28","doi-asserted-by":"publisher","unstructured":"Hussein HAM, Walker LR, Abdel-Raouf UM, Desouky SA, Montasser AKM, Akula SM (2015) Beyond RGD: virus interactions with integrins. Arch Virol. 160:11 160:2669\u20132681. https:\/\/doi.org\/10.1007\/S00705-015-2579-8","DOI":"10.1007\/S00705-015-2579-8"},{"key":"1485_CR29","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/J.VACCINE.2019.05.019","volume":"37","author":"I Fernandez-Sainz","year":"2019","unstructured":"Fernandez-Sainz I, Gavitt TD, Koster M, Ramirez-Medina E, Rodriguez YY, Wu P, Silbart LK, de Los ST, Szczepanek SM (2019) The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine. Vaccine 37:3435\u20133442. https:\/\/doi.org\/10.1016\/J.VACCINE.2019.05.019","journal-title":"Vaccine"},{"key":"1485_CR30","doi-asserted-by":"publisher","first-page":"21868","DOI":"10.1038\/s41598-022-26462-x","volume":"12","author":"J Jiao","year":"2022","unstructured":"Jiao J, Wu P (2022) A meta-analysis: the efficacy and effectiveness of polypeptide vaccines protect pigs from foot and mouth disease. Sci Rep 12:21868. https:\/\/doi.org\/10.1038\/s41598-022-26462-x","journal-title":"Sci Rep"},{"key":"1485_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13567-015-0273-1","volume":"46","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhu Z, Zhang M, Zheng H (2015) Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses. Vet Res 46:127. https:\/\/doi.org\/10.1186\/s13567-015-0273-1","journal-title":"Vet Res"},{"key":"1485_CR32","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1007\/s00253-020-10810-w","volume":"104","author":"H Yuan","year":"2020","unstructured":"Yuan H, Li N, Li P, Bai X, Sun P, Bao H, Gong X, Ma X, Cao Y, Li K, Fu Y, Zhang J, Li D, Chen Y, Zhang J, Lu Z, Liu Z (2020) Modification of the second translation initiation site restricts the replication of foot-and-mouth disease virus in PK-15 cells. Appl Microbiol Biotechnol 104:8455\u20138466. https:\/\/doi.org\/10.1007\/s00253-020-10810-w","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/life11060500","volume":"11","author":"J Newman","year":"2021","unstructured":"Newman J, Rowlands DJ, Tuthill TJ (2021) An engineered maturation cleavage provides a recombinant mimic of foot-and-mouth disease virus capsid assembly-disassembly. Life 11:500. https:\/\/doi.org\/10.3390\/life11060500","journal-title":"Life"},{"key":"1485_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/J.VIROL.2022.03.006","volume":"570","author":"T Kristensen","year":"2022","unstructured":"Kristensen T, Normann P, Belsham GJ (2022) The N-terminal region (VP4) of the foot-and-mouth disease capsid precursor (P1\u20132A) is not required during its synthesis to allow subsequent processing by the 3C protease. Virology 570:29\u201334. https:\/\/doi.org\/10.1016\/J.VIROL.2022.03.006","journal-title":"Virology"},{"issue":"2","key":"1485_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/vaccines8020254","volume":"8","author":"MJ Lee","year":"2020","unstructured":"Lee MJ, Jo H, Park SH, Ko M-K, Kim S-M, Kim B, Park J-H (2020) Advanced foot-and-mouth disease vaccine platform for stimulation of simultaneous cellular and humoral immune responses. Vaccines 8:254. https:\/\/doi.org\/10.3390\/vaccines8020254","journal-title":"Vaccines"},{"key":"1485_CR36","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1128\/JVI.79.12.7698-7706.2005","volume":"79","author":"A Nayak","year":"2005","unstructured":"Nayak A, Goodfellow IG, Belsham GJ (2005) Factors required for the uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol 79:7698. https:\/\/doi.org\/10.1128\/JVI.79.12.7698-7706.2005","journal-title":"J Virol"},{"key":"1485_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel J, Gack MU (2020) RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol 20:537\u2013551. https:\/\/doi.org\/10.1038\/s41577-020-0288-3","journal-title":"Nat Rev Immunol"},{"key":"1485_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/v15030797","volume":"15","author":"Q Li","year":"2023","unstructured":"Li Q, Wubshet AK, Wang Y, Heath L, Zhang J (2023) B and T cell epitopes of the incursionary foot-and-mouth disease virus serotype SAT2 for vaccine development. Viruses 15:797. https:\/\/doi.org\/10.3390\/v15030797","journal-title":"Viruses"},{"key":"1485_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vetmic.2013.04.028","volume":"166","author":"X Li","year":"2013","unstructured":"Li X, Wang J, Liu J, Li Z, Wang Y, Xue Y, Li X, Cao H, Zheng SJ (2013) Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells. Vet Microbiol 166:35\u201346. https:\/\/doi.org\/10.1016\/j.vetmic.2013.04.028","journal-title":"Vet Microbiol"},{"key":"1485_CR40","doi-asserted-by":"publisher","first-page":"e00588","DOI":"10.1128\/JVI.00588-19","volume":"93","author":"W Zhang","year":"2019","unstructured":"Zhang W, Yang F, Zhu Z, Yang Y, Wang Z, Cao W, Dang W, Li L, Mao R, Liu Y, Tian H, Zhang K, Liu X, Ma J, Zheng H (2019) Cellular DNAJA3, a novel VP1-interacting protein, inhibits foot-and-mouth disease virus replication by inducing lysosomal degradation of VP1 and attenuating its antagonistic role in the beta interferon signaling pathway. J Virol 93:e00588-19. https:\/\/doi.org\/10.1128\/JVI.00588-19","journal-title":"J Virol"},{"key":"1485_CR41","doi-asserted-by":"publisher","first-page":"e01350","DOI":"10.1128\/JVI.01350-19","volume":"94","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Li W, Zhang X, Wang C, Gao L, Yang F, Cao W, Li K, Tian H, Liu X, Zhang K, Zheng H (2020) Foot-and-mouth disease virus capsid protein VP1 interacts with host ribosomal protein SA to maintain activation of the MAPK signal pathway and promote virus replication. J Virol 94:e01350-19. https:\/\/doi.org\/10.1128\/JVI.01350-19","journal-title":"J Virol"},{"key":"1485_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/15548627.2017.1405187","volume":"14","author":"P Sun","year":"2018","unstructured":"Sun P, Zhang S, Qin X, Chang X, Cui X, Li H, Zhang S, Gao H, Wang P, Zhang Z, Luo J, Li Z (2018) Foot-and-mouth disease virus capsid protein VP2 activates the cellular EIF2S1-ATF4 pathway and induces autophagy via HSPB1. Autophagy 14:336\u2013346. https:\/\/doi.org\/10.1080\/15548627.2017.1405187","journal-title":"Autophagy"},{"key":"1485_CR43","doi-asserted-by":"publisher","unstructured":"Mao R, Yang F, Sun D, Zhou X, Zhu Z, Guo X, Liu H, Tian H, Zhang K, Dang W, Wu Q, Ma X, Liu X, Zheng H (2019) The glycine locating at random coil of picornaviruses VP3 enhances viral pathogenicity by targeting p53 to promote apoptosis and autophagy.\u00a0https:\/\/doi.org\/10.1101\/718130","DOI":"10.1101\/718130"},{"key":"1485_CR44","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/15384101.2016.1151584","volume":"15","author":"D Li","year":"2016","unstructured":"Li D, Wei J, Yang F, Liu H-N, Zhu Z-X, Cao W-J, Li S, Liu X-T, Zheng H-X, Shu H-B (2016) Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-\u03b3 signal transduction pathways. Cell Cycle 15:850\u2013860. https:\/\/doi.org\/10.1080\/15384101.2016.1151584","journal-title":"Cell Cycle"},{"key":"1485_CR45","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1096\/fj.15-281410","volume":"30","author":"D Li","year":"2016","unstructured":"Li D, Yang W, Yang F, Liu H, Zhu Z, Lian K, Lei C, Li S, Liu X, Zheng H, Shu H (2016) The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-\u03b2 signaling pathway. FASEB J 30:1757\u20131766. https:\/\/doi.org\/10.1096\/fj.15-281410","journal-title":"FASEB J"},{"key":"1485_CR46","doi-asserted-by":"publisher","first-page":"e01438","DOI":"10.1128\/JVI.01438-19","volume":"93","author":"D Li","year":"2019","unstructured":"Li D, Yang W, Ren J, Ru Y, Zhang K, Fu S, Liu X, Zheng H (2019) The E3 ubiquitin ligase TBK1 mediates the degradation of multiple picornavirus VP3 proteins by phosphorylation and ubiquitination. J Virol 93:e01438\u201319. https:\/\/doi.org\/10.1128\/JVI.01438-19","journal-title":"J Virol"},{"key":"1485_CR47","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41419-019-1751-6","volume":"10","author":"D Li","year":"2019","unstructured":"Li D, Zhang J, Yang W, He Y, Ru Y, Fu S, Li L, Liu X, Zheng H (2019) Poly (rC) binding protein 2 interacts with VP0 and increases the replication of the foot-and-mouth disease virus. Cell Death Dis 10:516. https:\/\/doi.org\/10.1038\/s41419-019-1751-6","journal-title":"Cell Death Dis"},{"key":"1485_CR48","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41419-018-0940-z","volume":"9","author":"H-H Feng","year":"2018","unstructured":"Feng H-H, Zhu Z-X, Cao W-J, Yang F, Zhang X-L, Du X-L, Zhang K-S, Liu X-T, Zheng H-X (2018) Foot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression. Cell Death Dis 9:885. https:\/\/doi.org\/10.1038\/s41419-018-0940-z","journal-title":"Cell Death Dis"},{"key":"1485_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1099\/jgv.0.000747","volume":"98","author":"SH Guan","year":"2017","unstructured":"Guan SH, Belsham GJ (2017) Separation of foot-and-mouth disease virus leader protein activities; identification of mutants that retain efficient self-processing activity but poorly induce eIF4G cleavage. J Gen Virol 98:671\u2013680. https:\/\/doi.org\/10.1099\/jgv.0.000747","journal-title":"J Gen Virol"},{"key":"1485_CR50","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1128\/JVI.02589-10","volume":"85","author":"D Wang","year":"2011","unstructured":"Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, Chen Z, Xiao S (2011) The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 85:3758. https:\/\/doi.org\/10.1128\/JVI.02589-10","journal-title":"J Virol"},{"key":"1485_CR51","doi-asserted-by":"publisher","first-page":"e00922","DOI":"10.1128\/JVI.00922-18","volume":"93","author":"LJ Visser","year":"2019","unstructured":"Visser LJ, Medina GN, Rabouw HH, de Groot RJ, Langereis MA, de los Santos T, van Kuppeveld FJM, (2019) Foot-and-mouth disease virus leader protease cleaves G3BP1 and G3BP2 and inhibits stress granule formation. J Virol 93:e00922\u201318. https:\/\/doi.org\/10.1128\/JVI.00922-18","journal-title":"J Virol"},{"key":"1485_CR52","doi-asserted-by":"publisher","first-page":"1020262","DOI":"10.3389\/fimmu.2022.1020262","volume":"13","author":"A Weerawardhana","year":"2022","unstructured":"Weerawardhana A, Uddin MB, Choi J-H, Pathinayake P, Shin SH, Chathuranga K, Park J-H, Lee J-S (2022) Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5. Front Immunol 13:1020262. https:\/\/doi.org\/10.3389\/fimmu.2022.1020262","journal-title":"Front Immunol"},{"key":"1485_CR53","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3389\/fmicb.2020.02046","volume":"11","author":"J Peng","year":"2020","unstructured":"Peng J, Yi J, Yang W, Ren J, Wen Y, Zheng H, Li D (2020) Advances in foot-and-mouth disease virus proteins regulating host innate immunity. Front Microbiol 11:2046. https:\/\/doi.org\/10.3389\/fmicb.2020.02046","journal-title":"Front Microbiol"},{"key":"1485_CR54","doi-asserted-by":"publisher","first-page":"e00124","DOI":"10.1128\/JVI.00124-19","volume":"93","author":"H Liu","year":"2019","unstructured":"Liu H, Zhu Z, Xue Q, Yang F, Cao W, Zhang K, Liu X, Zheng H (2019) Foot-and-mouth disease virus antagonizes NOD2-mediated antiviral effects by inhibiting NOD2 protein expression. J Virol 93:e00124\u201319. https:\/\/doi.org\/10.1128\/JVI.00124-19","journal-title":"J Virol"},{"key":"1485_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011132","volume":"19","author":"H Liu","year":"2023","unstructured":"Liu H, Zhu Z, Xue Q, Yang F, Li Z, Xue Z, Cao W, He J, Guo J, Liu X, Shaw AE, King DP, Zheng H (2023) Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release. PLoS Pathog 19:e1011132. https:\/\/doi.org\/10.1371\/journal.ppat.1011132","journal-title":"PLoS Pathog"},{"key":"1485_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/15476286.2019.1700058","volume":"17","author":"X Zhi","year":"2020","unstructured":"Zhi X, Zhang Y, Sun S, Zhang Z, Dong H, Luo X, Wei Y, Lu Z, Dou Y, Wu R, Jiang Z, Weng C, Seong Seo H, Guo H (2020) NLRP3 inflammasome activation by Foot-and-mouth disease virus infection mainly induced by viral RNA and non-structural protein 2B. RNA Biol 17:335\u2013349. https:\/\/doi.org\/10.1080\/15476286.2019.1700058","journal-title":"RNA Biol"},{"key":"1485_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.viruses.2020.198247","volume":"292","author":"H Lalzampuia","year":"2021","unstructured":"Lalzampuia H, Ganji VK, Elango S, Krishnaswamy N, Umapathi V, Reddy GR, Sanyal A, Dechamma HJ (2021) Expression of foot-and-mouth disease virus non-structural protein 3A upregulates the expression of autophagy and immune response genes in vitro. Virus Res 292:198247. https:\/\/doi.org\/10.1016\/j.viruses.2020.198247","journal-title":"Virus Res"},{"key":"1485_CR58","doi-asserted-by":"publisher","first-page":"e02086","DOI":"10.1128\/JVI.02086-19","volume":"94","author":"W Yang","year":"2020","unstructured":"Yang W, Li D, Ru Y, Bai J, Ren J, Zhang J, Li L, Liu X, Zheng H (2020) Foot-and-mouth disease virus 3A protein causes upregulation of autophagy-related protein LRRC25 to inhibit the G3BP1-mediated RIG-like helicase-signaling pathway. J Virol 94:e02086\u201319. https:\/\/doi.org\/10.1128\/JVI.02086-19","journal-title":"J Virol"},{"key":"1485_CR59","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/V8030082","volume":"8","author":"D Sun","year":"2016","unstructured":"Sun D, Chen S, Cheng A, Wang M (2016) Roles of the picornaviral 3C proteinase in the viral life cycle and host cells. Viruses 8:82. https:\/\/doi.org\/10.3390\/V8030082","journal-title":"Viruses"},{"key":"1485_CR60","doi-asserted-by":"publisher","first-page":"9311","DOI":"10.1128\/JVI.00722-12","volume":"86","author":"D Wang","year":"2012","unstructured":"Wang D, Fang L, Li K, Zhong H, Fan J, Ouyang C, Zhang H, Duan E, Luo R, Zhang Z, Liu X, Chen H, Xiao S (2012) Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol 86:9311\u20139322. https:\/\/doi.org\/10.1128\/JVI.00722-12","journal-title":"J Virol"},{"key":"1485_CR61","doi-asserted-by":"publisher","first-page":"e2561","DOI":"10.1038\/cddis.2016.489","volume":"8","author":"X Fan","year":"2017","unstructured":"Fan X, Han S, Yan D, Gao Y, Wei Y, Liu X, Liao Y, Guo H, Sun S (2017) Foot-and-mouth disease virus infection suppresses autophagy and NF-\u043aB antiviral responses via degradation of ATG5-ATG12 by 3Cpro. Cell Death Dis 8:e2561. https:\/\/doi.org\/10.1038\/cddis.2016.489","journal-title":"Cell Death Dis"},{"key":"1485_CR62","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1128\/JVI.03668-13","volume":"88","author":"Y Du","year":"2014","unstructured":"Du Y, Bi J, Liu J, Liu X, Wu X, Jiang P, Yoo D, Zhang Y, Wu J, Wan R, Zhao X, Guo L, Sun W, Cong X, Chen L, Wang J (2014) 3C pro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1\/STAT2 nuclear translocation. J Virol 88:4908\u20134920. https:\/\/doi.org\/10.1128\/JVI.03668-13","journal-title":"J Virol"},{"key":"1485_CR63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12985-015-0452-8","volume":"12","author":"DK Rai","year":"2015","unstructured":"Rai DK, Lawrence P, Kloc A, Schafer E, Rieder E (2015) Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections. Virol J 12:224. https:\/\/doi.org\/10.1186\/s12985-015-0452-8","journal-title":"Virol J"},{"key":"1485_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.virusres.2012.08.018","volume":"170","author":"J Wang","year":"2012","unstructured":"Wang J, Wang Y, Liu J, Ding L, Zhang Q, Li X, Cao H, Tang J, Zheng SJ (2012) A critical role of N-myc and STAT interactor (Nmi) in foot-and-mouth disease virus (FMDV) 2C-induced apoptosis. Virus Res 170:59\u201365. https:\/\/doi.org\/10.1016\/j.virusres.2012.08.018","journal-title":"Virus Res"},{"key":"1485_CR65","doi-asserted-by":"publisher","first-page":"12080","DOI":"10.1128\/JVI.01610-12","volume":"86","author":"DP Gladue","year":"2012","unstructured":"Gladue DP, O\u2019Donnell V, Baker-Branstetter R, Holinka LG, Pacheco JM, Fernandez-Sainz I, Lu Z, Brocchi E, Baxt B, Piccone ME, Rodriguez L, Borca MV (2012) Foot-and-mouth disease virus nonstructural protein 2C interacts with Beclin1, modulating virus replication. J Virol 86:12080\u201312090. https:\/\/doi.org\/10.1128\/JVI.01610-12","journal-title":"J Virol"},{"key":"1485_CR66","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/S12250-019-00148-7","volume":"34","author":"Q Xue","year":"2019","unstructured":"Xue Q, Liu H, Zeng Q, Zheng H, Xue Q, Cai X (2019) The DEAD-box RNA helicase DDX1 interacts with the viral protein 3D and inhibits foot-and-mouth disease virus replication. Virol Sin 34:610\u2013617. https:\/\/doi.org\/10.1007\/S12250-019-00148-7","journal-title":"Virol Sin"},{"key":"1485_CR67","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","volume":"17","author":"M Mahapatra","year":"2018","unstructured":"Mahapatra M, Parida S (2018) Foot and mouth disease vaccine strain selection: current approaches and future perspectives. Expert Rev Vaccines 17:577\u2013591. https:\/\/doi.org\/10.1080\/14760584.2018.1492378","journal-title":"Expert Rev Vaccines"},{"key":"1485_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.554383","volume":"8","author":"RM de Villegas","year":"2021","unstructured":"de Villegas RM, Seki C, Mattion NM, Konig GA (2021) Functional and in silico characterization of neutralizing interactions between antibodies and the foot-and-mouth disease virus immunodominant antigenic site. Front Vet Sci 8:554383. https:\/\/doi.org\/10.3389\/fvets.2021.554383","journal-title":"Front Vet Sci"},{"key":"1485_CR69","doi-asserted-by":"crossref","unstructured":"El-Rhman MM\u0650, Salem SA, Bazid A-HI, El-Hassan DJA (2021) Molecular and serological typing of foot-and-mouth disease virus serotypes currently circulating in Egypt. Iraqi J Vet Sci. 35:581\u2013588.","DOI":"10.33899\/ijvs.2020.127327.1495"},{"key":"1485_CR70","doi-asserted-by":"publisher","first-page":"347","DOI":"10.33899\/ijvs.2022.133432.2227","volume":"37","author":"GF El-Bagoury","year":"2023","unstructured":"El-Bagoury GF, El-Deen MRN, Fakhry HM (2023) Genetic characterization and phylogenetic analysis of foot and mouth disease virus vaccine strains and recent field isolate. Iraqi J Vet Sci 37:347\u2013354. https:\/\/doi.org\/10.33899\/ijvs.2022.133432.2227","journal-title":"Iraqi J Vet Sci"},{"key":"1485_CR71","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.vaccine.2021.01.042","volume":"39","author":"W Xu","year":"2021","unstructured":"Xu W, Yang M (2021) Genetic variation and evolution of foot\u2013and\u2013mouth disease virus serotype A in relation to vaccine matching. Vaccine 39:1420\u20131427. https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.042","journal-title":"Vaccine"},{"key":"1485_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10123-021-00178-w","volume":"25","author":"Y Tesfaye","year":"2022","unstructured":"Tesfaye Y, Khan F, Gelaye E (2022) Vaccine matching and antigenic variability of foot-and-mouth disease virus serotypes O and A from 2018 Ethiopian isolates. Int Microbiol 25:47\u201359. https:\/\/doi.org\/10.1007\/s10123-021-00178-w","journal-title":"Int Microbiol"},{"key":"1485_CR73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/vetsci11060272","volume":"11","author":"YM Eltahir","year":"2024","unstructured":"Eltahir YM, Ishag HZA, Parekh K, Wood BA, Ludi A, King DP, Bensalah OK, Khan RA, Shah AAM, Kayaf K, Mohamed MS (2024) Foot and mouth disease vaccine matching and post-vaccination assessment in Abu Dhabi, United Arab Emirates. Vet Sci 11:272. https:\/\/doi.org\/10.3390\/vetsci11060272","journal-title":"Vet Sci"},{"key":"1485_CR74","doi-asserted-by":"publisher","first-page":"e01308","DOI":"10.1128\/JVI.01308-21","volume":"95","author":"Y He","year":"2021","unstructured":"He Y, Li K, Wang L, Sun Z, Cao Y, Li P, Sun P, Bao H, Zhou S, Wang S, Bai X, Liu X, Zhao L, Fan X, Liu Z, Lu Z, Yang C, Lou Z (2021) Structures of foot-and-mouth disease virus with bovine neutralizing antibodies reveal the determinant of intraserotype cross-neutralization. J Virol 95:e01308\u201321. https:\/\/doi.org\/10.1128\/JVI.01308-21","journal-title":"J Virol"},{"key":"1485_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009507","volume":"17","author":"Y He","year":"2021","unstructured":"He Y, Li K, Cao Y, Sun Z, Li P, Bao H, Wang S, Zhu G, Bai X, Sun P, Liu X, Yang C, Liu Z, Lu Z, Rao Z, Lou Z (2021) Structures of foot-and-mouth disease virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralization. PLoS Pathog 17:e1009507. https:\/\/doi.org\/10.1371\/journal.ppat.1009507","journal-title":"PLoS Pathog"},{"key":"1485_CR76","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1743-422X-9-191","volume":"9","author":"M Xue","year":"2012","unstructured":"Xue M, Wang H, Li W, Zhou G, Tu Y, Yu L (2012) Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus. Virol J 9:191. https:\/\/doi.org\/10.1186\/1743-422X-9-191","journal-title":"Virol J"},{"key":"1485_CR77","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/TBED.13687","volume":"68","author":"MR Islam","year":"2021","unstructured":"Islam MR, Rahman MS, Al AM, Alam ASMRU, Siddique MA, Sultana M, Hossain MA (2021) Evidence of combined effect of amino acid substitutions within G-H and B-C loops of VP1 conferring serological heterogeneity in foot-and-mouth disease virus serotype A. Transbound Emerg Dis 68:375\u2013384. https:\/\/doi.org\/10.1111\/TBED.13687","journal-title":"Transbound Emerg Dis"},{"key":"1485_CR78","doi-asserted-by":"publisher","first-page":"1147652","DOI":"10.3389\/FMICB.2023.1147652\/FULL","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Li Y, Ma J, Wu R, Zou X, Liu Y, Zhao Q, Zhu Y (2023) Molecular evolution, diversity, and adaptation of foot-and-mouth disease virus serotype O in Asia. Front Microbiol 14:1147652. https:\/\/doi.org\/10.3389\/FMICB.2023.1147652\/FULL","journal-title":"Front Microbiol"},{"key":"1485_CR79","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1099\/jgv.0.001204","volume":"100","author":"E Martel","year":"2019","unstructured":"Martel E, Forzono E, Kurker R, Clark BA, Neilan JG, Puckette M (2019) Effect of foot-and-mouth disease virus 3C protease B2 \u03b2-strand proline mutagenesis on expression and processing of the P1 polypeptide using a plasmid expression vector. J Gen Virol 100:446\u2013456. https:\/\/doi.org\/10.1099\/jgv.0.001204","journal-title":"J Gen Virol"},{"key":"1485_CR80","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1128\/JVI.00577-06","volume":"80","author":"A Burman","year":"2006","unstructured":"Burman A, Clark S, Abrescia NGA, Fry EE, Stuart DI, Jackson T (2006) Specificity of the VP1 GH loop of foot-and-mouth disease virus for \u03b1v integrins. J Virol 80:9798. https:\/\/doi.org\/10.1128\/JVI.00577-06","journal-title":"J Virol"},{"key":"1485_CR81","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1743-422X-11-132","volume":"11","author":"X Bai","year":"2014","unstructured":"Bai X, Bao H, Li P, Wei W, Zhang M, Sun P, Cao Y, Lu Z, Fu Y, Xie B, Chen Y, Li D, Luo J, Liu Z (2014) Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor. Virol J 11:132. https:\/\/doi.org\/10.1186\/1743-422X-11-132","journal-title":"Virol J"},{"key":"1485_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1007509","volume":"15","author":"T Kristensen","year":"2019","unstructured":"Kristensen T, Belsham GJ (2019) Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites. PLoS Pathog 15:e1007509. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1007509","journal-title":"PLoS Pathog"},{"key":"1485_CR83","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3390\/v12121405","volume":"12","author":"SY Park","year":"2020","unstructured":"Park SY, Lee J-M, Kim A-Y, Park SH, Kim J-S, Kim H, Park J-W, Park J-H, Ko Y-J, Park C-K (2020) Application of heparin affinity chromatography to produce a differential vaccine without eliciting antibodies against the nonstructural proteins of the serotype O foot-and-mouth disease viruses. Viruses 12:1405. https:\/\/doi.org\/10.3390\/v12121405","journal-title":"Viruses"},{"key":"1485_CR84","doi-asserted-by":"publisher","first-page":"e00081","DOI":"10.1128\/JVI.00081-17","volume":"91","author":"DK Rai","year":"2017","unstructured":"Rai DK, Segundo FD-S, Campagnola G, Keith A, Schafer EA (2017) Attenuation of foot-and-mouth disease virus by engineered viral polymerase fidelity. J Virol 91:e00081\u201317. https:\/\/doi.org\/10.1128\/JVI.00081-17","journal-title":"J Virol"},{"key":"1485_CR85","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/vaccines9040308","volume":"9","author":"J-H Hwang","year":"2021","unstructured":"Hwang J-H, Lee G, Kim A, Park J-H, Lee MJ, Kim B, Kim S-M (2021) A vaccine strain of the A\/ASIA\/Sea-97 lineage of foot-and-mouth disease virus with a single amino acid substitution in the P1 region that is adapted to suspension culture provides high immunogenicity. Vaccines 9:308. https:\/\/doi.org\/10.3390\/vaccines9040308","journal-title":"Vaccines"},{"key":"1485_CR86","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00253-020-10370-z","volume":"104","author":"VV Dhanesh","year":"2020","unstructured":"Dhanesh VV, Hosamani M, Basagoudanavar SH, Saravanan P, Biswal JK, Selvan RPT, Madhavan A, Sehrish K, Sanyal A, Sreenivasa BP (2020) Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine. Appl Microbiol Biotechnol 104:2589\u20132602. https:\/\/doi.org\/10.1007\/s00253-020-10370-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR87","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.1038\/s41598-024-59755-4","volume":"14","author":"J Jiao","year":"2024","unstructured":"Jiao J, Wu P (2024) A meta-analysis on the potency of foot-and-mouth disease vaccines in different animal models. Sci Rep 14:8931. https:\/\/doi.org\/10.1038\/s41598-024-59755-4","journal-title":"Sci Rep"},{"key":"1485_CR88","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fvets.2016.00102","volume":"3","author":"NA Lyons","year":"2016","unstructured":"Lyons NA, Lyoo YS, King DP, Paton DJ (2016) Challenges of generating and maintaining protective vaccine-induced immune responses for foot-and-mouth disease virus in pigs. Front Vet Sci 3:102. https:\/\/doi.org\/10.3389\/fvets.2016.00102","journal-title":"Front Vet Sci"},{"key":"1485_CR89","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/vaccines7030090","volume":"7","author":"RK Singh","year":"2019","unstructured":"Singh RK, Sharma GK, Mahajan S, Dhama K, Basagoudanavar SH, Hosamani M, Sreenivasa BP, Chaicumpa W, Gupta VK, Sanyal A (2019) Foot-and-mouth disease virus: immunobiology, advances in vaccines and vaccination strategies addressing vaccine failures\u2014an Indian perspective. Vaccines 7:90. https:\/\/doi.org\/10.3390\/vaccines7030090","journal-title":"Vaccines"},{"key":"1485_CR90","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","volume":"12","author":"U Wiedermann","year":"2016","unstructured":"Wiedermann U, Garner-Spitzer E, Wagner A (2016) Primary vaccine failure to routine vaccines: Why and what to do? Hum Vaccin Immunother 12:239\u2013243. https:\/\/doi.org\/10.1080\/21645515.2015.1093263","journal-title":"Hum Vaccin Immunother"},{"key":"1485_CR91","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/VMRR.S319761","volume":"12","author":"A Kenubih","year":"2021","unstructured":"Kenubih A (2021) Foot and mouth disease vaccine development and challenges in inducing long-lasting immunity: trends and current perspectives. Vet Med 12:205. https:\/\/doi.org\/10.2147\/VMRR.S319761","journal-title":"Vet Med"},{"key":"1485_CR92","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4149\/av_2022_304","volume":"66","author":"C \u00c7ok\u00e7ali\u015fkan","year":"2022","unstructured":"\u00c7ok\u00e7ali\u015fkan C, T\u00fcrko\u011flu T, Sareyy\u00fcpo\u011flu B, Tuncer-G\u00f6ktuna P, \u00d6zbilge BB, Uzunlu E, K\u00fcrk\u00e7\u00fc A, Uzun EA, G\u00fclyaz V (2022) Evaluation of Quil-A, E. coli DNA and Montanide\u2122 ISA 206 adjuvant combination on the antibody response to foot-and-mouth disease vaccine in sheep. Acta Virol 66:197\u2013205. https:\/\/doi.org\/10.4149\/av_2022_304","journal-title":"Acta Virol"},{"key":"1485_CR93","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13567-024-01383-x","volume":"55","author":"M Ren","year":"2024","unstructured":"Ren M, Abdullah SW, Pei C, Guo H, Sun S (2024) Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections. Vet Res 55:128. https:\/\/doi.org\/10.1186\/s13567-024-01383-x","journal-title":"Vet Res"},{"key":"1485_CR94","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3389\/fphar.2018.01060","volume":"9","author":"S Yan","year":"2018","unstructured":"Yan S, Xu K, Li L, Gu W, Rolfe BE, Xu ZP (2018) The pathways for layered double hydroxide nanoparticles to enhance antigen (cross)-presentation on immune cells as adjuvants for protein vaccines. Front Pharmacol 9:1060. https:\/\/doi.org\/10.3389\/fphar.2018.01060","journal-title":"Front Pharmacol"},{"key":"1485_CR95","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12917-020-02689-6","volume":"16","author":"P Wu","year":"2020","unstructured":"Wu P, Zhang Y, Yin X, He Y, Zhang Q, Chen C (2020) Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs. BMC Vet Res 16:474. https:\/\/doi.org\/10.1186\/s12917-020-02689-6","journal-title":"BMC Vet Res"},{"key":"1485_CR96","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.3390\/ma16155467","volume":"16","author":"DO Govea-Alonso","year":"2023","unstructured":"Govea-Alonso DO, Garc\u00eda-Soto MJ, Mendoza-P\u00e9rez ES, Farf\u00e1n-Castro S, Fuente D, Gonz\u00e1lez-Ortega O, Rosales-Mendoza S (2023) Assessing the adjuvant effect of layered double hydroxides (LDH) on BALB\/c mice. Materials 16:5467. https:\/\/doi.org\/10.3390\/ma16155467","journal-title":"Materials"},{"key":"1485_CR97","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virusres.2017.10.010","volume":"243","author":"M Bhatt","year":"2018","unstructured":"Bhatt M, Mohapatra JK, Pandey LK, Mohanty NN, Das B, Prusty BR, Pattnaik B (2018) Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus. Virus Res 243:36\u201343. https:\/\/doi.org\/10.1016\/j.virusres.2017.10.010","journal-title":"Virus Res"},{"key":"1485_CR98","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/vaccines11071156","volume":"11","author":"JY Kim","year":"2023","unstructured":"Kim JY, Lee J-H, Yang JM, Lee S-Y, Park SY, Jin JS, Kim D, Park J-W, Park J-H, Park SH, Ko Y-J (2023) Production of foot-and-mouth disease type O and A vaccine antigens on a pilot scale and determination of optimal amount of antigen for monovalent vaccines. Vaccines 11:1156. https:\/\/doi.org\/10.3390\/vaccines11071156","journal-title":"Vaccines"},{"key":"1485_CR99","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1016\/j.vaccine.2018.07.003","volume":"36","author":"C Jayeshbhai","year":"2018","unstructured":"Jayeshbhai C, Hajam IA, Verma AK, Bhanuprakash V, Kondabattula G, Kishore S (2018) Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA\u2122 206 adjuvanted foot-and-mouth disease vaccine in mice model. Vaccine 36:5318\u20135324. https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.003","journal-title":"Vaccine"},{"key":"1485_CR100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1746-6148-8-57","volume":"8","author":"P Li","year":"2012","unstructured":"Li P, Bai X, Sun P, Li D, Lu Z, Cao Y, Fu Y, Bao H, Chen Y, Xie B, Liu Z (2012) Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics. BMC Vet Res 8:57. https:\/\/doi.org\/10.1186\/1746-6148-8-57","journal-title":"BMC Vet Res"},{"key":"1485_CR101","doi-asserted-by":"publisher","first-page":"e00155","DOI":"10.1128\/JVI.00155-17","volume":"91","author":"S-Y Lee","year":"2017","unstructured":"Lee S-Y, Lee Y-J, Kim R-H, Park J-N, Park M-E, Ko M-K, Choi J-H, Chu J-Q, Lee K-N, Kim S-M, Tark D, Lee H-S, Ko Y-J, Seo M-G, Park J-W, Kim B, Lee M-H, Lee J-S, Park J-H (2017) Rapid engineering of foot-and-mouth disease vaccine and challenge viruses. J Virol 91:e00155\u201317. https:\/\/doi.org\/10.1128\/JVI.00155-17","journal-title":"J Virol"},{"key":"1485_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055228","volume":"8","author":"H Zheng","year":"2013","unstructured":"Zheng H, Guo J, Jin Y, Yang F, He J, Lv L, Zhang K, Wu Q, Liu X, Cai X (2013) Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development. PLoS One 8:e55228. https:\/\/doi.org\/10.1371\/journal.pone.0055228","journal-title":"PLoS ONE"},{"key":"1485_CR103","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/vaccines11020271","volume":"11","author":"SY Hwang","year":"2023","unstructured":"Hwang SY, Shin SH, Kim HM, Shin S, Lee MJ, Kim S-M, Lee J-S, Park J-H (2023) Evaluation of vaccine strains developed for efficient, broad-range protection against foot-and-mouth disease type O. Vaccines 11:271. https:\/\/doi.org\/10.3390\/vaccines11020271","journal-title":"Vaccines"},{"key":"1485_CR104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13567-022-01072-7","volume":"53","author":"P Li","year":"2022","unstructured":"Li P, Huang S, Zha J, Sun P, Li D, Bao H, Cao Y, Bai X, Fu Y, Ma X, Li K, Yuan H, Zhang J, Zhao Z, Wang J, Zhang K, Chen Y, Zhang Q, Qi S, Liu Z, Lu Z (2022) Evaluation of immunogenicity and cross-reactive responses of vaccines prepared from two chimeric serotype O foot-and-mouth disease viruses in pigs and cattle. Vet Res 53:56. https:\/\/doi.org\/10.1186\/s13567-022-01072-7","journal-title":"Vet Res"},{"key":"1485_CR105","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/vaccines12020185","volume":"12","author":"JY Kim","year":"2024","unstructured":"Kim JY, Park SY, Park SH, Lee G, Jin J-S, Kim D, Park J-H, Jeong S-Y, Ko Y-J (2024) Evaluation of foot-and-mouth disease (FMD) virus Asia1 genotype-V as an FMD vaccine candidate: study on vaccine antigen production yield and inactivation kinetics. Vaccines 12:185. https:\/\/doi.org\/10.3390\/vaccines12020185","journal-title":"Vaccines"},{"key":"1485_CR106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pathogens9020129","volume":"9","author":"M Eschbaumer","year":"2020","unstructured":"Eschbaumer M, Dill V, Carlson JC, Arzt J, Stenfeldt C, Krug PW, Hardham JM, Stegner JE, Rodriguez LL, Rieder E (2020) Foot-and-mouth disease virus lacking the leader protein and containing two negative DIVA markers (FMDV LL3B3D A24) is highly attenuated in pigs. Pathogens 9:129. https:\/\/doi.org\/10.3390\/pathogens9020129","journal-title":"Pathogens"},{"key":"1485_CR107","doi-asserted-by":"publisher","first-page":"1028077","DOI":"10.3389\/fvets.2022.1028077","volume":"9","author":"PA Azzinaro","year":"2022","unstructured":"Azzinaro PA, Medina GN, Rai D, Ramirez-Medina E, Spinard E, Rodriguez-Calzada M, Zhu J, Rieder E (2022) Mutation of FMDV Lpro H138 residue drives viral attenuation in cell culture and in vivo in swine. Front Vet Sci 9:1028077. https:\/\/doi.org\/10.3389\/fvets.2022.1028077","journal-title":"Front Vet Sci"},{"key":"1485_CR108","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/JVI.02167-15","volume":"90","author":"FD-S Segundo","year":"2016","unstructured":"Segundo FD-S, Medina GN, Ramirez-Medina E, Velazquez-Salinas L, Koster M, Grubman MJ (2016) Synonymous deoptimization of foot-and-mouth disease virus causes attenuation in vivo while inducing a strong neutralizing antibody response. J Virol 90:1298\u20131310. https:\/\/doi.org\/10.1128\/JVI.02167-15","journal-title":"J Virol"},{"key":"1485_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.610286","volume":"11","author":"F Diaz-San Segundo","year":"2021","unstructured":"Diaz-San Segundo F, Medina GN, Spinard E, Kloc A, Ramirez-Medina E, Azzinaro P, Mueller S, Rieder E (2021) Use of synonymous deoptimization to derive modified live attenuated strains of foot and mouth disease virus. Front Microbiol 11:610286. https:\/\/doi.org\/10.3389\/fmicb.2020.610286","journal-title":"Front Microbiol"},{"key":"1485_CR110","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/14760584.2020.1791090","volume":"19","author":"OC Bolanos-Martinez","year":"2020","unstructured":"Bolanos-Martinez OC, Rosales-Mendoza S (2020) The potential of plant-made vaccines to fight picornavirus. Expert Rev Vaccines 19:599\u2013609. https:\/\/doi.org\/10.1080\/14760584.2020.1791090","journal-title":"Expert Rev Vaccines"},{"key":"1485_CR111","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1440-1711.2005.01338.x","volume":"83","author":"MJD Santos","year":"2005","unstructured":"Santos MJD, Wigdorovitz A (2005) Transgenic plants for the production of veterinary vaccines. Immunol Cell Biol 83:229\u2013238. https:\/\/doi.org\/10.1111\/j.1440-1711.2005.01338.x","journal-title":"Immunol Cell Biol"},{"key":"1485_CR112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/08828240151061383","volume":"14","author":"C Carrillo","year":"2001","unstructured":"Carrillo C, Wigdorovitz A, Trono K, Santos MJD, Casta\u00f1\u00f3n S, Sadir AM, Ordas R, Escribano JM, Borca MV (2001) Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol 14:49\u201357. https:\/\/doi.org\/10.1089\/08828240151061383","journal-title":"Viral Immunol"},{"key":"1485_CR113","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1743-422X-8-268","volume":"8","author":"L Zhang","year":"2011","unstructured":"Zhang L, Zhang J, Chen H, Zhou J, Ma L, Ding Y, Liu Y (2011) Research in advance for FMD Novel Vaccines. Virol J 8:268. https:\/\/doi.org\/10.1186\/1743-422X-8-268","journal-title":"Virol J"},{"key":"1485_CR114","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1023\/A:1009676322162\/METRICS","volume":"3","author":"EE Hood","year":"1997","unstructured":"Hood EE, Witcher DR, Maddock S, Meyer T, Baszczynski C, Bailey M, Flynn P, Register J, Marshall L, Bond D, Kulisek E, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh RJ, Hernan R, Kappel WK, Ritland D et al (1997) Commercial production of avidin from transgenic maizecharacterization of transformant, production, processing, extraction and purification. Mol Breed 3:291\u2013306. https:\/\/doi.org\/10.1023\/A:1009676322162\/METRICS","journal-title":"Mol Breed"},{"key":"1485_CR115","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1467-7652.2010.00500.x","volume":"8","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Li J, Pu H, Jin J, Zhang X, Chen M, Wang B, Han C, Yu J, Li D (2010) Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides. Plant Biotechnol J 8:506\u2013523. https:\/\/doi.org\/10.1111\/j.1467-7652.2010.00500.x","journal-title":"Plant Biotechnol J"},{"key":"1485_CR116","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1023\/A:1024140114505","volume":"25","author":"M Sun","year":"2003","unstructured":"Sun M, Qian K, Su N, Chang H, Liu J, Chen G (2003) Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol Lett 25:1087\u20131092. https:\/\/doi.org\/10.1023\/A:1024140114505","journal-title":"Biotechnol Lett"},{"key":"1485_CR117","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1080\/21645515.2017.1330236","volume":"13","author":"JJ Suschak","year":"2017","unstructured":"Suschak JJ, Williams JA, Schmaljohn CS (2017) Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Hum Vaccin Immunother 13:2837\u20132848. https:\/\/doi.org\/10.1080\/21645515.2017.1330236","journal-title":"Hum Vaccin Immunother"},{"key":"1485_CR118","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1016\/j.vaccine.2008.07.060","volume":"26","author":"B Yang","year":"2008","unstructured":"Yang B, Lan X, Li X, Yin X, Li B, Han X, Li Y, Zhang Z, Liu J (2008) A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5\u2032UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Vaccine 26:5477\u20135483. https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.060","journal-title":"Vaccine"},{"key":"1485_CR119","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.antiviral.2011.07.017","volume":"92","author":"B Borrego","year":"2011","unstructured":"Borrego B, Argilaguet JM, P\u00e9rez-Mart\u00edn E, Dominguez J, P\u00e9rez-Filgueira M, Escribano JM, Sobrino F, Rodriguez F (2011) A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge. Antiviral Res 92:359\u2013363. https:\/\/doi.org\/10.1016\/j.antiviral.2011.07.017","journal-title":"Antiviral Res"},{"key":"1485_CR120","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/vaccines11020386","volume":"11","author":"M Puckette","year":"2023","unstructured":"Puckette M, Clark BA, Barrera J, Neilan JG, Rasmussen MV (2023) Evaluation of DNA vaccine candidates against foot-and-mouth disease virus in cattle. Vaccines (Basel) 11:386. https:\/\/doi.org\/10.3390\/vaccines11020386","journal-title":"Vaccines (Basel)"},{"key":"1485_CR121","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/562356","volume":"2010","author":"Q Zou","year":"2010","unstructured":"Zou Q, Wu B, He X, Zhang Y, Kang Y, Jin J, Xu H, Liu H, Wang B (2010) Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. J Biomed Biotechnol 2010:562356. https:\/\/doi.org\/10.1155\/2010\/562356","journal-title":"J Biomed Biotechnol"},{"key":"1485_CR122","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/dna.2007.0581","volume":"26","author":"Y Hu","year":"2007","unstructured":"Hu Y, Jin H, Du X, Xiao C, Luo D, Wang B, She R (2007) Effects of chronic heat stress on immune responses of the foot-and-mouth disease DNA vaccination. DNA Cell Biol 26:619\u2013626. https:\/\/doi.org\/10.1089\/dna.2007.0581","journal-title":"DNA Cell Biol"},{"key":"1485_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.199008","volume":"323","author":"CM de Sousa Lacerda","year":"2023","unstructured":"de Sousa Lacerda CM, Almeida NBF, dos Santos VCF, Plentz F, de Andrade ASR (2023) Foot-and-mouth disease virus: DNA aptamer selection for the 3ABC protein. Virus Res 323:199008. https:\/\/doi.org\/10.1016\/j.virusres.2022.199008","journal-title":"Virus Res"},{"key":"1485_CR124","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/vaccines11061111","volume":"11","author":"P Semkum","year":"2023","unstructured":"Semkum P, Thangthamniyom N, Chankeeree P, Keawborisuth C, Theerawatanasirikul S, Lekcharoensuk P (2023) The application of the gibson assembly method in the production of two pKLS3 vector-derived infectious clones of foot-and-mouth disease virus. Vaccines 11:1111. https:\/\/doi.org\/10.3390\/vaccines11061111","journal-title":"Vaccines"},{"key":"1485_CR125","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.rvsc.2017.07.001","volume":"115","author":"W Liu","year":"2017","unstructured":"Liu W, Yang B, Wang M, Wang H, Yang D, Ma W, Zhou G, Yu L (2017) Identification of a conformational neutralizing epitope on the VP1 protein of type A foot-and-mouth disease virus. Res Vet Sci 115:374\u2013381. https:\/\/doi.org\/10.1016\/j.rvsc.2017.07.001","journal-title":"Res Vet Sci"},{"key":"1485_CR126","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13770-019-00228-5","volume":"17","author":"S-Y Yoon","year":"2020","unstructured":"Yoon S-Y, Kang S-K, Lee H-B, Oh S-H, Kim W-S, Li H-S, Bok J-D, Cho C-S, Choi Y-J (2020) Enhanced efficacy of immunization with a foot-and-mouth disease multi-epitope subunit vaccine using mannan-decorated inulin microparticles. Tissue Eng Regen Med 17:33\u201344. https:\/\/doi.org\/10.1007\/s13770-019-00228-5","journal-title":"Tissue Eng Regen Med"},{"key":"1485_CR127","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.antiviral.2016.03.005","volume":"129","author":"E Blanco","year":"2016","unstructured":"Blanco E, Guerra B, de la Torre BG, Defaus S, Dekker A, Andreu D, Sobrino F (2016) Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide. Antiviral Res 129:74\u201380. https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.005","journal-title":"Antiviral Res"},{"key":"1485_CR128","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1099\/0022-1317-68-6-1637","volume":"68","author":"Q-C Xie","year":"1987","unstructured":"Xie Q-C, McCahon D, Crowther JR, Belsham GJ, McCullough KC (1987) Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol 68:1637\u20131647. https:\/\/doi.org\/10.1099\/0022-1317-68-6-1637","journal-title":"J Gen Virol"},{"key":"1485_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.vetmic.2007.06.022","volume":"126","author":"M Mahapatra","year":"2008","unstructured":"Mahapatra M, Aggarwal N, Cox S, Statham RJ, Knowles NJ, Barnett PV, Paton DJ (2008) Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains. Vet Microbiol 126:40\u201350. https:\/\/doi.org\/10.1016\/j.vetmic.2007.06.022","journal-title":"Vet Microbiol"},{"key":"1485_CR130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0042-6822(88)90390-X","volume":"162","author":"JW Stave","year":"1988","unstructured":"Stave JW, Card JL, Morgan DO, Vakharia VN (1988) Neutralization sites of type 01 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 162:21\u201329. https:\/\/doi.org\/10.1016\/0042-6822(88)90390-X","journal-title":"Virology"},{"key":"1485_CR131","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1099\/0022-1317-79-7-1687","volume":"79","author":"D Ansell","year":"1998","unstructured":"Ansell D, Pullen L, Samuel AR, Barnett PV, Parkhouse RM, Butcher RN (1998) Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. J Gen Virol 79:1687\u20131697. https:\/\/doi.org\/10.1099\/0022-1317-79-7-1687","journal-title":"J Gen Virol"},{"key":"1485_CR132","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1099\/vir.0.060939-0","volume":"95","author":"AS Asfor","year":"2014","unstructured":"Asfor AS, Upadhyaya S, Knowles NJ, King DP, Paton DJ, Mahapatra M (2014) Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus. J Gen Virol 95:1104\u20131116. https:\/\/doi.org\/10.1099\/vir.0.060939-0","journal-title":"J Gen Virol"},{"key":"1485_CR133","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.vaccine.2013.08.102","volume":"32","author":"S Upadhyaya","year":"2014","unstructured":"Upadhyaya S, Ayelet G, Paul G, King DP, Paton DJ, Mahapatra M (2014) Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East. Vaccine 32:631\u2013638. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.102","journal-title":"Vaccine"},{"key":"1485_CR134","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1099\/jgv.0.001259","volume":"100","author":"M Mahapatra","year":"2019","unstructured":"Mahapatra M, Upadhyaya S, Parida S (2019) Identification of novel epitopes in serotype O foot-and-mouth disease virus by in vitro immune selection. J Gen Virol 100:804\u2013811. https:\/\/doi.org\/10.1099\/jgv.0.001259","journal-title":"J Gen Virol"},{"key":"1485_CR135","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1099\/0022-1317-75-11-2937","volume":"75","author":"M-JC van Lierop","year":"1994","unstructured":"van Lierop M-JC, van Noort JM, Wagenaar JPA, Rutten VPMG, Langeveld J, Meloen RH, Hensen EJ (1994) T cell-stimulatory fragments of foot-and-mouth disease virus released by mild treatment with cathepsin D. J Gen Virol 75:2937\u20132946. https:\/\/doi.org\/10.1099\/0022-1317-75-11-2937","journal-title":"J Gen Virol"},{"key":"1485_CR136","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1128\/jvi.74.10.4902-4907.2000","volume":"74","author":"E Blanco","year":"2000","unstructured":"Blanco E, McCullough K, Summerfield A, Fiorini J, Andreu D, Chiva C, Borr\u00e1s E, Barnett P, Sobrino F (2000) Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol 74:4902\u20134907. https:\/\/doi.org\/10.1128\/jvi.74.10.4902-4907.2000","journal-title":"J Virol"},{"key":"1485_CR137","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1128\/CVI.00417-10","volume":"18","author":"JR Patch","year":"2011","unstructured":"Patch JR, Pedersen LE, Toka FN, Moraes M, Grubman MJ, Nielsen M, Jungersen G, Buus S, Golde WT (2011) Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination. Clin Vaccine Immunol 18:280\u2013288. https:\/\/doi.org\/10.1128\/CVI.00417-10","journal-title":"Clin Vaccine Immunol"},{"key":"1485_CR138","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12917-018-1742-3","volume":"14","author":"F Gao","year":"2018","unstructured":"Gao F, Feng L, Jiang P, Li Z, Gao H, Zhai X, Zhang Z, Hu X (2018) Expression, purification, crystallization and preliminary X-ray diffraction analysis of swine leukocyte antigen 2 complexed with a CTL epitope AS64 derived from Asia1 serotype of foot-and-mouth disease virus. BMC Vet Res 14:407. https:\/\/doi.org\/10.1186\/s12917-018-1742-3","journal-title":"BMC Vet Res"},{"key":"1485_CR139","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vetimm.2016.07.012","volume":"181","author":"LE Pedersen","year":"2016","unstructured":"Pedersen LE, Patch JR, Kenney M, Glabman RA, Nielsen M, Jungersen G, Buus S, Golde WT (2016) Expanding specificity of class I restricted CD8+ T cells for viral epitopes following multiple inoculations of swine with a human adenovirus vectored foot-and-mouth disease virus (FMDV) vaccine. Vet Immunol Immunopathol 181:59\u201367. https:\/\/doi.org\/10.1016\/j.vetimm.2016.07.012","journal-title":"Vet Immunol Immunopathol"},{"key":"1485_CR140","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.rvsc.2019.11.002","volume":"128","author":"S Ning","year":"2020","unstructured":"Ning S, Wang Z-B, Qi P, Xiao J, Wang X-J (2020) Crystallization of SLA-2*04:02:02 complexed with a CTL epitope derived from FMDV. Res Vet Sci 128:90\u201398. https:\/\/doi.org\/10.1016\/j.rvsc.2019.11.002","journal-title":"Res Vet Sci"},{"key":"1485_CR141","doi-asserted-by":"publisher","first-page":"13020","DOI":"10.1002\/anie.201401058","volume":"53","author":"TA Hill","year":"2014","unstructured":"Hill TA, Shepherd NE, Diness F, Fairlie DP (2014) Constraining cyclic peptides to mimic protein structure motifs. Angew Chem Int Ed Engl 53:13020\u201313041. https:\/\/doi.org\/10.1002\/anie.201401058","journal-title":"Angew Chem Int Ed Engl"},{"key":"1485_CR142","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/298030a0","volume":"298","author":"JL Bittle","year":"1982","unstructured":"Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30\u201333. https:\/\/doi.org\/10.1038\/298030a0","journal-title":"Nature"},{"key":"1485_CR143","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1128\/jvi.66.4.2187-2194.1992","volume":"66","author":"TR Doel","year":"1992","unstructured":"Doel TR, Doel CM, Staple RF, DiMarchi R (1992) Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide. J Virol 66:2187\u20132194. https:\/\/doi.org\/10.1128\/jvi.66.4.2187-2194.1992","journal-title":"J Virol"},{"key":"1485_CR144","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1126\/science.3008333","volume":"232","author":"R DiMarchi","year":"1986","unstructured":"DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N (1986) Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639\u2013641. https:\/\/doi.org\/10.1126\/science.3008333","journal-title":"Science"},{"key":"1485_CR145","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/jvi.71.4.2606-2614.1997","volume":"71","author":"O Taboga","year":"1997","unstructured":"Taboga O, Tami C, Carrillo E, N\u00fa\u00f1ez JI, Rodr\u00edguez A, Sa\u00edz JC, Blanco E, Valero ML, Roig X, Camarero JA, Andreu D, Mateu MG, Giralt E, Domingo E, Sobrino F, Palma EL (1997) A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 71:2606\u20132614. https:\/\/doi.org\/10.1128\/jvi.71.4.2606-2614.1997","journal-title":"J Virol"},{"key":"1485_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1051\/VETRES:2001106","volume":"32","author":"F Sobrino","year":"2001","unstructured":"Sobrino F, S\u00e1iz M, Jim\u00e9nez-Clavero MA, N\u00fa\u00f1ez JI, Rosas MF, Baranowski E, Ley V (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32:1\u201330. https:\/\/doi.org\/10.1051\/VETRES:2001106","journal-title":"Vet Res"},{"key":"1485_CR147","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.1007\/s00253-019-10081-0","volume":"103","author":"W Liu","year":"2019","unstructured":"Liu W, Shao J, Chen D, Chang Y, Chang H, Zhang Y (2019) Identification of three linear B cell epitopes against non-structural protein 3ABC of FMDV using monoclonal antibodies. Appl Microbiol Biotechnol 103:8075\u20138086. https:\/\/doi.org\/10.1007\/s00253-019-10081-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR148","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1292\/jvms.19-0559","volume":"82","author":"H-S Lee","year":"2020","unstructured":"Lee H-S, Park S-Y, Kim A-Y, Lee S-O, Kim J-S, Kim H, Youn H-J, Ko Y-J (2020) Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate. J Vet Med Sci 82:1155\u20131159. https:\/\/doi.org\/10.1292\/jvms.19-0559","journal-title":"J Vet Med Sci"},{"key":"1485_CR149","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/vaccines11091487","volume":"11","author":"SY Hwang","year":"2023","unstructured":"Hwang SY, Shin SH, Park S-H, Lee MJ, Kim S-M, Lee J-S, Park J-H (2023) Serological conversion through a second exposure to inactivated foot-and-mouth disease virus expressing the JC epitope on the viral surface. Vaccines 11:1487. https:\/\/doi.org\/10.3390\/vaccines11091487","journal-title":"Vaccines"},{"key":"1485_CR150","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.micpath.2019.04.019","volume":"132","author":"M Doosti","year":"2019","unstructured":"Doosti M, Nassiri M, Nasiri K, Tahmoorespur M, Zibaee S (2019) Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2\/FcIgG in BALB\/c mice. Microb Pathog 132:30\u201337. https:\/\/doi.org\/10.1016\/j.micpath.2019.04.019","journal-title":"Microb Pathog"},{"key":"1485_CR151","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3390\/vaccines10122181","volume":"10","author":"WAG Chathuranga","year":"2022","unstructured":"Chathuranga WAG, Hewawaduge C, Nethmini NAN, Kim T-H, Kim JH, Ahn Y-H, Yoon I-J, Yoo S-S, Park J-H, Lee J-S (2022) Efficacy of a novel multiepitope vaccine candidate against foot-and-mouth disease virus serotype O and A. Vaccines 10:2181. https:\/\/doi.org\/10.3390\/vaccines10122181","journal-title":"Vaccines"},{"key":"1485_CR152","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1128\/CVI.00236-10","volume":"18","author":"JJ Shao","year":"2011","unstructured":"Shao JJ, Wong CK, Lin T, Lee SK, Cong GZ, Sin FWY, Du JZ, Gao SD, Liu XT, Cai XP, Xie Y, Chang HY, Liu JX (2011) Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin Vaccine Immunol 18:143\u2013149. https:\/\/doi.org\/10.1128\/CVI.00236-10","journal-title":"Clin Vaccine Immunol"},{"key":"1485_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110103","volume":"596","author":"J Shao","year":"2024","unstructured":"Shao J, Liu W, Gao S, Chang H, Guo H (2024) A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs. Virol 596:110103. https:\/\/doi.org\/10.1016\/j.virol.2024.110103","journal-title":"Virol"},{"key":"1485_CR154","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12934-017-0648-2","volume":"16","author":"H-B Lee","year":"2017","unstructured":"Lee H-B, Piao D-C, Lee J-Y, Choi J-Y, Bok J-D, Cho C-S, Kang S-K, Choi Y-J (2017) Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate. Microb Cell Fact 16:33. https:\/\/doi.org\/10.1186\/s12934-017-0648-2","journal-title":"Microb Cell Fact"},{"key":"1485_CR155","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/vaccines12010064","volume":"12","author":"SH Shin","year":"2024","unstructured":"Shin SH, Hwang SY, Kim H-M, Shin SH, Ko M-K, Lee MJ, Kim S-M, Park J-H (2024) Evaluation of a vaccine candidate designed for broad-spectrum protection against type A foot-and-mouth disease in Asia. Vaccines 12:64. https:\/\/doi.org\/10.3390\/vaccines12010064","journal-title":"Vaccines"},{"key":"1485_CR156","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1007\/s00253-019-09691-5","volume":"103","author":"B Cui","year":"2019","unstructured":"Cui B, Liu X, Zhou P, Fang Y, Zhao D, Zhang Y, Wang Y (2019) Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin. Appl Microbiol Biotechnol 103:3367\u20133379. https:\/\/doi.org\/10.1007\/s00253-019-09691-5","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR157","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00253-014-6129-1","volume":"99","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Pan L, Ding Y, Zhou P, Lv J, Chen H, Fang Y, Liu X, Chang H, Zhang J, Shao J, Lin T, Zhao F, Zhang Y, Wang Y (2015) Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle. Appl Microbiol Biotechnol 99:1389\u20131398. https:\/\/doi.org\/10.1007\/s00253-014-6129-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR158","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2020.02.018","volume":"121","author":"Y Lei","year":"2020","unstructured":"Lei Y, Shao J, Ma F, Lei C, Chang H, Zhang Y (2020) Enhanced efficacy of a multi-epitope vaccine for type A and O foot-and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist. Mol Immunol 121:118\u2013126. https:\/\/doi.org\/10.1016\/j.molimm.2020.02.018","journal-title":"Mol Immunol"},{"key":"1485_CR159","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biologicals.2019.05.003","volume":"60","author":"A Aghaei","year":"2019","unstructured":"Aghaei A, Moghbeli M, Kargar M, Nazarian S, Kafilzadeh F (2019) Cloning and expression of a novel synthetic gene containing VP1 and 3A in Bacillus subtilis as a vaccine candidate against foot-and-mouth disease virus. Biologicals 60:55\u201359. https:\/\/doi.org\/10.1016\/j.biologicals.2019.05.003","journal-title":"Biologicals"},{"key":"1485_CR160","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1134\/S0006297911030072","volume":"76","author":"EP Andrianova","year":"2011","unstructured":"Andrianova EP, Krementsugskaia SR, Lugovskaia NN, Mayorova TK, Borisov VV, Eldarov MA, Ravin NV, Folimonov AS, Skryabin KG (2011) Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs. Biochemistry 76:339\u2013346. https:\/\/doi.org\/10.1134\/S0006297911030072","journal-title":"Biochemistry"},{"key":"1485_CR161","doi-asserted-by":"publisher","DOI":"10.1101\/2022.12.23.520716","author":"H InasI","year":"2022","unstructured":"InasI H, Raouf YA, Alhaj M, SanaI M, Elhassan RM, OubiO S, Mustafa E, Mohamed A, Ahmed K, Mona M, MohamedM S, Hassan MA (2022) Epitopes- based vaccine design against foot and mouth disease SAT2 serotype from Sudanese isolate by using immunoinformatic approaches. bioRxiv. https:\/\/doi.org\/10.1101\/2022.12.23.520716","journal-title":"bioRxiv"},{"key":"1485_CR162","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/475960","volume":"2013","author":"E Blanco","year":"2013","unstructured":"Blanco E, Cubillos C, Moreno N, B\u00e1rcena J, de la Torre BG, Andreu D, Sobrino F (2013) B epitope multiplicity and B\/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines. Clin Dev Immunol 2013:475960. https:\/\/doi.org\/10.1155\/2013\/475960","journal-title":"Clin Dev Immunol"},{"key":"1485_CR163","doi-asserted-by":"publisher","first-page":"3497401","DOI":"10.1155\/2018\/3497401","volume":"2018","author":"I Soria","year":"2018","unstructured":"Soria I, Quattrocchi V, Langellotti C, P\u00e9rez-Filgueira M, Pega J, Gnazzo V, Romera S, Schammas J, Bucafusco D, Di GS, de la Torre BG, Andreu D, Sobrino F, Blanco E, Zamorano P (2018) Immune response and partial protection against heterologous foot-and-mouth disease virus induced by dendrimer peptides in cattle. J Immunol Res 2018:3497401. https:\/\/doi.org\/10.1155\/2018\/3497401","journal-title":"J Immunol Res"},{"key":"1485_CR164","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/vaccines8030406","volume":"8","author":"S Defaus","year":"2020","unstructured":"Defaus S, Forner M, Ca\u00f1as-Arranz R, de Le\u00f3n P, Bustos MJ, Rodr\u00edguez-Pulido M, Blanco E, Sobrino F, Andreu D (2020) Designing functionally versatile, highly immunogenic peptide-based multiepitopic vaccines against foot-and-mouth disease virus. Vaccines 8:406. https:\/\/doi.org\/10.3390\/vaccines8030406","journal-title":"Vaccines"},{"key":"1485_CR165","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fvets.2020.00498","volume":"7","author":"R Ca\u00f1as-Arranz","year":"2020","unstructured":"Ca\u00f1as-Arranz R, de Le\u00f3n P, Forner M, Defaus S, Bustos MJ, Torres E, Andreu D, Blanco E, Sobrino F (2020) Immunogenicity of a dendrimer B2T peptide harboring a T-cell epitope from FMDV non-structural protein 3D. Front Vet Sci 7:498. https:\/\/doi.org\/10.3389\/fvets.2020.00498","journal-title":"Front Vet Sci"},{"key":"1485_CR166","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7774\/cevr.2013.2.2.97","volume":"2","author":"Y Choi","year":"2013","unstructured":"Choi Y, Chang J (2013) Viral vectors for vaccine applications. Clin Exp Vaccine Res 2:97. https:\/\/doi.org\/10.7774\/cevr.2013.2.2.97","journal-title":"Clin Exp Vaccine Res"},{"key":"1485_CR167","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1016\/j.vaccine.2010.09.011","volume":"28","author":"A D\u2019Antuono","year":"2010","unstructured":"D\u2019Antuono A, Laimbacher AS, La Torre J, Tribulatti V, Romanutti C, Zamorano P, Quattrocchi V, Schraner EM, Ackermann M, Fraefel C, Mattion N (2010) HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine 28:7363\u20137372. https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.011","journal-title":"Vaccine"},{"key":"1485_CR168","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/vaccines9010022","volume":"9","author":"Y Zhi","year":"2021","unstructured":"Zhi Y, Ji HJ, Guo H, Lim JH, Byun E-B, Kim WS, Seo HS (2021) Salmonella vaccine vector system for foot-and-mouth disease virus and evaluation of its efficacy with virus-like particles. Vaccines 9:22. https:\/\/doi.org\/10.3390\/vaccines9010022","journal-title":"Vaccines"},{"key":"1485_CR169","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.vaccine.2018.02.074","volume":"36","author":"AR De Vleeschauwer","year":"2018","unstructured":"De Vleeschauwer AR, Zhou X, Lefebvre DJ, Garnier A, Watier F, Pignon C, Lacour SA, Zientara S, Bakkali-Kassimi L, De Clercq K, Klonjkowski B (2018) A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs. Vaccine 36:2193\u20132198. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.074","journal-title":"Vaccine"},{"key":"1485_CR170","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.vetmic.2017.03.019","volume":"203","author":"BP Sreenivasa","year":"2017","unstructured":"Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Selvan RPT, Hosamani M, Saravanan P, Basagoudanavar SH (2017) Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle. Vet Microbiol 203:196\u2013201. https:\/\/doi.org\/10.1016\/j.vetmic.2017.03.019","journal-title":"Vet Microbiol"},{"key":"1485_CR171","doi-asserted-by":"publisher","first-page":"1360397","DOI":"10.3389\/fmicb.2024.1360397","volume":"15","author":"SE Attreed","year":"2024","unstructured":"Attreed SE, Silva C, Rodriguez-Calzada M, Mogulothu A, Abbott S, Azzinaro P, Canning P, Skidmore L, Nelson J, Knudsen N, Medina GN (2024) Prophylactic treatment with PEGylated bovine IFN\u03bb3 effectively bridges the gap in vaccine-induced immunity against FMD in cattle. Front Microbiol 15:1360397. https:\/\/doi.org\/10.3389\/fmicb.2024.1360397","journal-title":"Front Microbiol"},{"key":"1485_CR172","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fvets.2020.00594","volume":"7","author":"V Quattrocchi","year":"2020","unstructured":"Quattrocchi V, Bidart J, Mignaqui AC, Ruiz V, Ferella A, Langellotti C, Gammella M, Ferraris S, Carrillo J, Wigdorovitz A, Durocher Y, Cardillo SB, Charleston B, Zamorano PI (2020) Bovine dendritic cell activation, T cell proliferation and antibody responses to foot-and-mouth disease, is similar with inactivated virus and virus like particles. Front Vet Sci 7:594. https:\/\/doi.org\/10.3389\/fvets.2020.00594","journal-title":"Front Vet Sci"},{"key":"1485_CR173","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.rvsc.2013.07.007","volume":"95","author":"SA Bhat","year":"2013","unstructured":"Bhat SA, Saravanan P, Hosamani M, Basagoudanavar SH, Sreenivasa BP, Tamilselvan RP, Venkataramanan R (2013) Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. Res Vet Sci 95:1217\u20131223. https:\/\/doi.org\/10.1016\/j.rvsc.2013.07.007","journal-title":"Res Vet Sci"},{"key":"1485_CR174","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biologicals.2015.12.002","volume":"44","author":"VM Vivek Srinivas","year":"2016","unstructured":"Vivek Srinivas VM, Basagoudanavar SH, Hosamani M (2016) IRES mediated expression of viral 3C protease for enhancing the yield of FMDV empty capsids using baculovirus system. Biologicals 44:64\u201368. https:\/\/doi.org\/10.1016\/j.biologicals.2015.12.002","journal-title":"Biologicals"},{"key":"1485_CR175","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.vaccine.2024.04.092","volume":"42","author":"H Song","year":"2024","unstructured":"Song H, Waheed Abdullah S, Yin S, Dong H, Zhang Y, Tan S, Bai M, Ding Y, Teng Z, Sun S, Guo H (2024) Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs. Vaccine 42:3789\u20133801. https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.092","journal-title":"Vaccine"},{"key":"1485_CR176","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.vaccine.2012.01.069","volume":"30","author":"E Crisci","year":"2012","unstructured":"Crisci E, Fraile L, Moreno N, Blanco E, Cabez\u00f3n R, Costa C, Muss\u00e1 T, Baratelli M, Martinez-Orellana P, Ganges L, Mart\u00ednez J, B\u00e1rcena J, Montoya M (2012) Chimeric calicivirus-like particles elicit specific immune responses in pigs. Vaccine 30:2427\u20132439. https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.069","journal-title":"Vaccine"},{"key":"1485_CR177","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12896-016-0285-6","volume":"16","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Chen H-Y, Wang Y, Yin B, Lv C, Mo X, Yan H, Xuan Y, Huang Y, Pang W, Li X, Yuan YA, Tian K (2016) Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol 16:56. https:\/\/doi.org\/10.1186\/s12896-016-0285-6","journal-title":"BMC Biotechnol"},{"key":"1485_CR178","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/jmv.25554","volume":"91","author":"Y Lei","year":"2019","unstructured":"Lei Y, Shao J, Zhao F, Li Y, Lei C, Ma F, Chang H, Zhang Y (2019) Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate. J Med Virol 91:2142\u20132152. https:\/\/doi.org\/10.1002\/jmv.25554","journal-title":"J Med Virol"},{"key":"1485_CR179","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00253-021-11747-4","volume":"106","author":"E Garay","year":"2022","unstructured":"Garay E, Fontana D, Leschiutta L, Kratje R, Prieto C (2022) Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications. Appl Microbiol Biotechnol 106:579\u2013592. https:\/\/doi.org\/10.1007\/s00253-021-11747-4","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR180","doi-asserted-by":"publisher","first-page":"8883","DOI":"10.1007\/s00253-018-9278-9","volume":"102","author":"VK Ganji","year":"2018","unstructured":"Ganji VK, Biswal JK, Lalzampuia H, Basagoudanavar SH, Saravanan P, Selvan RPT, Umapathi V, Reddy GR, Sanyal A, Dechamma HJ (2018) Mutation in the VP2 gene of P1\u20132A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O. Appl Microbiol Biotechnol 102:8883\u20138893. https:\/\/doi.org\/10.1007\/s00253-018-9278-9","journal-title":"Appl Microbiol Biotechnol"},{"key":"1485_CR181","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12934-020-01394-1","volume":"19","author":"N Behloul","year":"2020","unstructured":"Behloul N, Baha S, Liu Z, Wei W, Zhu Y, Rao Y, Shi R, Meng J (2020) Design and development of a chimeric vaccine candidate against zoonotic hepatitis E and foot-and-mouth disease. Microb Cell Fact 19:137. https:\/\/doi.org\/10.1186\/s12934-020-01394-1","journal-title":"Microb Cell Fact"},{"key":"1485_CR182","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.22227","volume":"24","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ge J, Li J, Li J, Zhang Y, Shi Y, Sun J, Wang Q, Zhang X, Zhao X (2023) Expression of FMD virus-like particles in yeast Hansenula polymorpha and immunogenicity of combine with CpG and aluminum adjuvant. J Vet Sci 24:e15. https:\/\/doi.org\/10.4142\/jvs.22227","journal-title":"J Vet Sci"},{"key":"1485_CR183","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.antiviral.2016.08.020","volume":"134","author":"Y Dong","year":"2016","unstructured":"Dong Y, Cai J, Chen H, Chen L (2016) Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease. Antiviral Res 134:108\u2013116. https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.020","journal-title":"Antiviral Res"},{"key":"1485_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2024.110192","volume":"296","author":"NMT Le","year":"2024","unstructured":"Le NMT, So K-K, Kim D-H (2024) Oral immunization against foot-and-mouth disease virus using recombinant Saccharomyces cerevisiae with the improved expression of the codon-optimized VP1 fusion protein. Vet Microbiol 296:110192. https:\/\/doi.org\/10.1016\/j.vetmic.2024.110192","journal-title":"Vet Microbiol"},{"key":"1485_CR185","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.addr.2018.12.013","volume":"145","author":"Q Bao","year":"2019","unstructured":"Bao Q, Li X, Han G, Zhu Y, Mao C, Yang M (2019) Phage-based vaccines. Adv Drug Deliv Rev 145:40\u201356. https:\/\/doi.org\/10.1016\/j.addr.2018.12.013","journal-title":"Adv Drug Deliv Rev"},{"key":"1485_CR186","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/vaccines11020436","volume":"11","author":"M Palma","year":"2023","unstructured":"Palma M (2023) Aspects of phage-based vaccines for protein and epitope immunization. Vaccines 11:436. https:\/\/doi.org\/10.3390\/vaccines11020436","journal-title":"Vaccines"},{"key":"1485_CR187","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10529-020-03012-x","volume":"43","author":"P Wu","year":"2021","unstructured":"Wu P, Yin X, Liu Q, Wu W, Chen C (2021) Recombinant T7 phage with FMDV AKT-III strain VP1 protein is a potential FMDV vaccine. Biotechnol Lett 43:35\u201341. https:\/\/doi.org\/10.1007\/s10529-020-03012-x","journal-title":"Biotechnol Lett"},{"key":"1485_CR188","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4823","volume":"6","author":"G Wang","year":"2018","unstructured":"Wang G, Liu Y, Feng H, Chen Y, Yang S, Wei Q, Wang J, Liu D, Zhang G (2018) Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus. PeerJ 6:e4823. https:\/\/doi.org\/10.7717\/peerj.4823","journal-title":"PeerJ"},{"key":"1485_CR189","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/vaccines10111817","volume":"10","author":"Z Lu","year":"2022","unstructured":"Lu Z, Yu S, Wang W, Chen W, Wang X, Wu K, Li X, Fan S, Ding H, Yi L, Chen J (2022) Development of foot-and-mouth disease vaccines in recent years. Vaccines 10:1817. https:\/\/doi.org\/10.3390\/vaccines10111817","journal-title":"Vaccines"},{"key":"1485_CR190","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.vetmic.2010.11.003","volume":"149","author":"M Mahapatra","year":"2011","unstructured":"Mahapatra M, Seki C, Upadhyaya S, Barnett PV, La TJ, Paton DJ (2011) Characterisation and epitope mapping of neutralising monoclonal antibodies to A24 Cruzeiro strain of FMDV. Vet Microbiol 149:242\u2013247. https:\/\/doi.org\/10.1016\/j.vetmic.2010.11.003","journal-title":"Vet Microbiol"},{"key":"1485_CR191","doi-asserted-by":"publisher","first-page":"8307","DOI":"10.1128\/JVI.00470-14","volume":"88","author":"PA Opperman","year":"2014","unstructured":"Opperman PA, Rotherham LS, Esterhuysen J, Charleston B, Juleff N, Capozzo AV, Theron J, Maree FF (2014) Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses. J Virol 88:8307\u20138318. https:\/\/doi.org\/10.1128\/JVI.00470-14","journal-title":"J Virol"},{"key":"1485_CR192","volume-title":"The in silico prediction of foot-and-mouth disease virus (FMDV) epitopes on the South African territories (SAT)1, SAT2 and SAT3 serotypes","author":"M Mukonyora","year":"2015","unstructured":"Mukonyora M (2015) The in silico prediction of foot-and-mouth disease virus (FMDV) epitopes on the South African territories (SAT)1, SAT2 and SAT3 serotypes. University of Pretoria, Master"},{"key":"1485_CR193","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/imm.13367","volume":"164","author":"S Mitoma","year":"2021","unstructured":"Mitoma S, Carr BV, Harvey Y, Moffat K, Sekiguchi S, Charleston B, Norimine J, Seago J (2021) The detection of long-lasting memory foot-and-mouth disease (FMD) virus serotype O-specific CD4<SUP>+<\/SUP> T cells from FMD-vaccinated cattle by bovine major histocompatibility complex class II tetramer. Immunology 164:266\u2013278. https:\/\/doi.org\/10.1111\/imm.13367","journal-title":"Immunology"},{"key":"1485_CR194","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4049\/jimmunol.146.2.749","volume":"146","author":"T Collen","year":"1991","unstructured":"Collen T, Dimarchi R, Doel TR (1991) A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146:749\u2013755","journal-title":"J Immunol"},{"key":"1485_CR195","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1099\/vir.0.032839-0","volume":"92","author":"FF Maree","year":"2011","unstructured":"Maree FF, Blignaut B, Esterhuysen JJ, de Beer TAP, Theron J, O\u2019Neill HG, Rieder E (2011) Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African territories types using virus neutralization data. J Gen Virol 92:2297\u20132309. https:\/\/doi.org\/10.1099\/vir.0.032839-0","journal-title":"J Gen Virol"},{"key":"1485_CR196","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.vetmic.2009.07.011","volume":"140","author":"Z-W Zhang","year":"2010","unstructured":"Zhang Z-W, Zhang Y-G, Wang Y-L, Pan L, Fang Y-Z, Jiang S-T, L\u00fc J-L, Zhou P (2010) Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1. Vet Microbiol 140:25\u201333. https:\/\/doi.org\/10.1016\/j.vetmic.2009.07.011","journal-title":"Vet Microbiol"},{"key":"1485_CR197","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.virusres.2006.05.006","volume":"121","author":"W Gerner","year":"2006","unstructured":"Gerner W, Denyer MS, Takamatsu H-H, Wileman TE, Wiesm\u00fcller K-H, Pfaff E, Saalm\u00fcller A (2006) Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c\/c and d\/d haplotype miniature swine. Virus Res 121:223\u2013228. https:\/\/doi.org\/10.1016\/j.virusres.2006.05.006","journal-title":"Virus Res"},{"key":"1485_CR198","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.1128\/JVI.77.16.8633-8639.2003","volume":"77","author":"B-J H\u00f6hlich","year":"2003","unstructured":"H\u00f6hlich B-J, Wiesm\u00fcller K-H, Schlapp T, Haas B, Pfaff E, Saalm\u00fcller A (2003) Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle. J Virol 77:8633\u20138639. https:\/\/doi.org\/10.1128\/JVI.77.16.8633-8639.2003","journal-title":"J Virol"},{"key":"1485_CR199","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/tbed.13497","volume":"67","author":"R Ca\u00f1as-Arranz","year":"2020","unstructured":"Ca\u00f1as-Arranz R, Forner M, Defaus S, Rodr\u00edguez-Pulido M, Le\u00f3n P, Torres E, Bustos MJ, Borrego B, S\u00e1iz M, Blanco E, Andreu D, Sobrino F (2020) A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease. Transbound Emerg Dis 67:1614\u20131622. https:\/\/doi.org\/10.1111\/tbed.13497","journal-title":"Transbound Emerg Dis"},{"key":"1485_CR200","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/vaccines9050470","volume":"9","author":"G Rangel","year":"2021","unstructured":"Rangel G, Barcena J, Moreno N, Mata CP, Caston JR, Alejo A, Blanco E (2021) Chimeric RHDV virus-like particles displaying foot-and-mouth disease virus epitopes elicit neutralizing antibodies and confer partial protection in pigs. Vaccines 9:470. https:\/\/doi.org\/10.3390\/vaccines9050470","journal-title":"Vaccines"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-025-01485-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:17:37Z","timestamp":1744003057000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-025-01485-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1186\/s13567-025-01485-0","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}